VEGFA and bronchopulmonary dysplasia: VEGF expression has been shown to be decreased in both experimental models of BPD and in preterm infants who develop adverse pulmonary outcomes [32, 49–51] and gene therapy with VEGF has been shown to improve alveolarization in a rat model of hyperoxic lung injury [32].